CNBX Pharmaceuticals (OTCMKTS:CNBX) Vs. IIPR, MSRT, GRWG, XXII, KSHB, NSAV, CANN, TRTC, PVSP, and NMUS
Should you be buying CNBX Pharmaceuticals stock or one of its competitors? The main competitors of CNBX Pharmaceuticals include Innovative Industrial Properties (IIPR), MassRoots (MSRT), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), Net Savings Link (NSAV), General Cannabis (CANN), Unrivaled Brands (TRTC), Pervasip (PVSP), and Nemus Bioscience (NMUS). These companies are all part of the "cannabis" industry.
CNBX Pharmaceuticals vs.
Innovative Industrial Properties (NYSE:IIPR) and CNBX Pharmaceuticals (OTCMKTS:CNBX) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings.
Innovative Industrial Properties received 183 more outperform votes than CNBX Pharmaceuticals when rated by MarketBeat users. Likewise, 61.97% of users gave Innovative Industrial Properties an outperform vote while only 60.26% of users gave CNBX Pharmaceuticals an outperform vote.
Innovative Industrial Properties has a net margin of 54.43% compared to CNBX Pharmaceuticals' net margin of 0.00%. Innovative Industrial Properties' return on equity of 7.91% beat CNBX Pharmaceuticals' return on equity.
66.9% of Innovative Industrial Properties shares are held by institutional investors. 1.5% of Innovative Industrial Properties shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Innovative Industrial Properties had 7 more articles in the media than CNBX Pharmaceuticals. MarketBeat recorded 8 mentions for Innovative Industrial Properties and 1 mentions for CNBX Pharmaceuticals. Innovative Industrial Properties' average media sentiment score of 0.60 beat CNBX Pharmaceuticals' score of 0.00 indicating that Innovative Industrial Properties is being referred to more favorably in the media.
Innovative Industrial Properties has higher revenue and earnings than CNBX Pharmaceuticals.
Innovative Industrial Properties presently has a consensus price target of $257.33, suggesting a potential upside of 96.12%. Given Innovative Industrial Properties' higher possible upside, analysts plainly believe Innovative Industrial Properties is more favorable than CNBX Pharmaceuticals.
Summary
Innovative Industrial Properties beats CNBX Pharmaceuticals on 12 of the 12 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
CNBX Pharmaceuticals (OTCMKTS:CNBX) vs. Its Competitors
CNBX Pharmaceuticals Competitors List